TY  - JOUR
UR  - https://doi.org/10.1016/j.ejca.2018.02.002
SN  - 1879-0852
ID  - discovery10045527
A1  - Rydzewska, LHM
A1  - Burdett, S
A1  - Vale, CL
A1  - Parmar, MKB
A1  - Tierney, JF
JF  - European Journal of Cancer
AV  - public
VL  - 94
SP  - 218
Y1  - 2018/05//
EP  - 229
TI  - Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
N1  - This version is the author accepted manuscript. For information on re-use, please refer to the publisher?s terms and conditions.
ER  -